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Abstract: We have performed 280 µs of unbiased molecular dynamics (MD) simulations to investigate
the effects of 12 different cancer mutations on Kelch-like ECH-associated protein 1 (KEAP1) (G333C,
G350S, G364C, G379D, R413L, R415G, A427V, G430C, R470C, R470H, R470S and G476R), one of the
frequently mutated proteins in lung cancer. The aim was to provide structural insight into the effects
of these mutants, including a new class of ANCHOR (additionally NRF2-complexed hypomorph)
mutant variants. Our work provides additional insight into the structural dynamics of mutants that
could not be analyzed experimentally, painting a more complete picture of their mutagenic effects.
Notably, blade-wise analysis of the Kelch domain points to stability as a possible target of cancer
in KEAP1. Interestingly, structural analysis of the R470C ANCHOR mutant, the most prevalent
missense mutation in KEAP1, revealed no significant change in structural stability or NRF2 binding
site dynamics, possibly indicating an covalent modification as this mutant’s mode of action.
Keywords: KEAP1; NRF2; cancer; protein stability; biophysics; bioinformatics; molecular dynamics;
simulation
1. Introduction
One of the major open problems in computational structural biology is predicting the
three-dimensional folded structure of a protein given its primary amino acid sequence.
This has remained practically unsolved for over 50 years [1], but 2020 ushered in a major
change: DeepMind’s AlphaFold 2, which utilizes a deep learning system, spectacularly
outperformed all other groups at the 14th Critical Assessment of protein Structure Predic-
tion (CASP) [2,3]. DeepMind’s paradigm-shifting breakthrough at CASP allowed them to
predict the three-dimensional structure of a protein given its primary amino acid sequence
with accuracy comparable to experimental methods. Herein, we consider a similarly in-
triguing sub-problem, predicting the change in the three-dimensional structure of a protein
under various amino acid substitutions, given its initial folded structure.
It has been well documented that many diseases, including cystic fibrosis [4], Parkin-
son’s [5], Rett syndrome [6] and some cancers [7], arise due to a single or only a handful
of amino acid substitutions in key proteins. These mutations tend to either disrupt the
delicate intramolecular scaffolding of a protein, destabilizing the folded state [8,9] or impair
the intermolecular interactions between a protein and its binding partners, often giving rise
to aberrant gene product production [10,11]. It is, therefore, no surprise that in the advent
of personalized medicine, the characterization of a patient’s unique proteome concerning
the stability and target binding of key proteins is highly desirable for the design of novel
therapeutics and treatment protocols [12–18].
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The development of in silico methods has primarily focused on either predicting the ef-
fect of mutations on stability [19] or binding affinity [20]. With respect to stability, the meth-
ods employed can be broadly classified as either sequence- or structure-based. Sequence-
based methods consider only the primary amino acid sequence. Historically, these have
employed sequence alignments and homology searches [21,22] but have more recently
employed machine-learning (ML) approaches [23–26]. Structure-based methods consider
the known three-dimensional structure of a protein and utilize potential-energy-based
approaches [27–29], structural modeling and sampling [30,31], normal mode analysis [32],
and ML techniques [33–38] to predict the impacts of mutations. While structure-based
methods tend to perform better than sequence-based methods, meta-analyses have demon-
strated the failure of these methods to accurately characterize mutations of buried amino
acids [39], and adequately control for the bias introduced by the training sets, which can of-
ten lack key thermodynamic parameters [15,19,40–43]. As a result, even the best predictive
methods have historically shown only about 60% accuracy [40,44–46].
Molecular dynamics (MD)-based methods have been increasingly successful in pre-
dicting the effects of point mutations on protein stability and, unlike static in silico methods,
can provide detailed atomistic information concerning wild-type and mutant protein dy-
namics [47–55], mutagenic changes in stability [56–59] and the effects of mutation on
target binding [60–64]. These insights may be difficult to obtain by experimental techniques
and are often beyond the reach of conventional in silico methods. As a result of increased
computational power, MD simulations have begun to reach experimentally relevant time
scales at the millisecond level [65].
Kelch-like ECH-associated protein 1 (KEAP1) is an oxidative stress sensor, functioning
as an adaptor for the Cullin-3 (CUL3) ubiquitin ligase, which regulates the activity of
nuclear factor erythroid 2-related factor 2 (NRF2), the master regulator of cytoprotective
gene expression [66]. Under resting conditions, KEAP1 dimerizes and the Kelch domain
of each protein monomer binds to one of the two motifs (ETGE or DLG) in NRF2’s Neh2
domain. This sequestering of NRF2 facilitates its ubiquitination and subsequent proteolysis,
therefore repressing cytoprotective gene expression [67]. Under oxidative stress, key
solvent-accessible cysteine residues in KEAP1 are post-translationally modified, resulting
in the release of NRF2 by KEAP1, increased translocation of NRF2 to the nucleus and
upregulation of cytoprotective genes [67]. Studies have shown that mutations at the
KEAP1-NRF2 interface are prevalent in cancer, and it is believed that some of the genes
regulated by NRF2 confer a chemoprotective phenotype to cancer cells [68].
Intriguingly, not all mutations in KEAP1 reside at this interface and the missense muta-
tion most frequently documented in KEAP1 in the COSMIC [69] cancer database is R470C,
which is curiously located distantly from the NRF2 binding site (Figure 1). A handful of
similar mutants have been identified and coined “additionally NRF2-complexed hypo-
morphs” (ANCHOR mutants) and appear to confer an increased affinity to KEAP1 for
NRF2 [70]. A previous study postulated that these mutations have an allosteric effect
via fluctuations that propagate through the Kelch domain and alter the binding site [71].
This has yet to be verified or in silico.
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Figure 1. Mutant locations and frequency in the Kelch domain. β-propeller Kelch domain of KEAP1 bound to the 16-mer
peptide encoding the ETGE motif from the Neh2 domain of NRF2 (yellow). The putty structure describes the mutational
frequency at the given position (red/large = high frequency, blue/small = low frequency). The 12 cancer mutants are listed
and indicated. Barplot shows the COSMIC [69] mutation frequency and corresponding location within the various blades
(I-VI) of the β-propeller structure. Red bars indicate the mutants studied in this work. Residues that roughly separate the
blades are indicated; note that blade I is a “junction blade” containing residues from the N- and C-termini (325–358 and
598–609). The Cullin-3 and NRF2 binding regions are also depicted.
In this work, we performed over 280µs of MD simulations to characterize 12 key
KEAP1 mutations that were chosen as a representative sample of the total mutations
present in the COSMIC database for the Kelch domain of KEAP1, and for which some
previous experimental binding and structural data were available [70–72]. For nine of these
mutants (G333C, G350S, G364C, G379D, R413L, G430C, R415G, A427V and G476R) nuclear
magnetic resonance (NMR) spectroscopy and isothermal titration calorimetry (ITC) were
used in an attempt to elucidate their effects on stability and target binding. Notably, five of
the nine mutants (G333C, G379D, R413L, G430C and G476R) were insoluble and could not
be characterized, leaving a significant knowledge gap [72].
Our results demonstrate that MD is capable of predicting the effects of mutations on
protein stability and can provide structural insights that are often difficult to gain from static
predictive methods. Specifically, we found that blades I, II and III in the Kelch β-propeller
structure appear to be the least stable, which, taken together with their observed mutational
frequency, points to stability as a possible target of cancer in the Kelch domain of KEAP1.
On the other hand, our structural and binding site analysis revealed no significant change
in structural fluctuations resulting from the R470C ANCHOR mutation, suggesting that




The starting protein structure was prepared from the Neh2-Kelch crystal structure
(PDB: 2FLU) [73] downloaded from the Protein Data Bank [74]. The 16-mer ETGE peptide
was removed from the complex, leaving only the Kelch domain to be simulated. MOD-
ELLER [75] was used to rebuild missing atoms, and PyMOL [76] was used to perform
residue substitution producing 13 unique structures (12 mutants and wild type). MD
simulations were performed using GROMACS 2018.7 [77] with the CHARMM36m force-
field [78] under periodic boundary conditions. The protein was centered in a rhombic
dodecahedral box such that all atoms were positioned at least 2.0 nm from the box edge.
The box was solvated using TIP3P explicit water [79] and K+ ions (6–8 depending on the
system) were added to maintain overall charge neutrality. The protonation states of all
ionizable residues were chosen on the basis of their most probable state at pH 7, and all
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simulations were conducted with the amino and carboxyl terminal ends of the protein left
uncapped (NH3+ and COO−, respectively).
2.2. Simulation Protocol
Each system contained approximately ∼57,000 atoms. Prior to equilibration, we used
the steepest descents algorithm to minimize the energy of each system. A single 100 ps
equilibration was run in the NPT ensemble at 310 K and 1 bar following energy minimiza-
tion to ensure system stability. During production runs, a constant temperature of 310 K
was maintained using the Parrinello–Donadio–Bussi velocity rescaling method [80] with a
coupling time of 1 ps; this approach has previously been shown to perform well for similar
biomolecular simulations [81,82]. The 310 K temperature was chosen to match physiologi-
cal conditions. A Parrinello–Rahman barostat [83] with a coupling time constant of 5 ps
was used to maintain the pressure at 1 bar. The Particle-mesh Ewald (PME) method [84]
with a Fourier spacing of 0.12 nm, and a real-space cut-off of 1.0 nm was used to calculate
the long-range electrostatic interactions. A 1.2 nm cut-off was used for the Lennard-Jones
interactions. Hydrogen bond lengths were constrained using the LINear Constraint Solver
(P-LINCS) [85]. The simulation time step was 2 fs. All mutant structures were simulated
for 10µs with one replicate (2 runs total), while the wild type was simulated for 10µs with
three replicates (4 runs total). The total simulation run time was 280µs.
2.3. Analyses
The Kelch domain is a β-propeller containing six blades connected by linkers (Figure 1).
For analysis purposes, these blades are defined accordingly: blade I [(325–358, 598–609)],
blade II [(359–409)], blade III (410–456), blade IV (457–503), blade V (504–550) and blade
VI (551–597). Note that blade I is a “junction blade” containing residues from the N- and
C-termini of the protein. To discern the global and local structural fluctuations of the
protein, the root mean square deviation (RMSD), moving root mean square deviation
(mRMSD) and root mean square fluctuation (RMSF) were calculated for all backbone atoms
following a least squares fit to the backbone of the reference structure. Given the structure
of the Kelch domain, a natural parameter choice is the anti-parallel β-sheet order parameter
(Saβ). Saβ measures the RMSD between all 6 residue segments in a protein and an idealized
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where ri − d0 is the backbone RMSD (in nm) of a given 6-residue fragment i from an ideal
β-sheet, N is the number of overlapping six-residue segments in the protein, and r0 = 0.8,
n = 8, and m = 12 are parameters defined in the original work [86]. A completely anti-
parallel, β-sheeted structure will have an Saβ value near N, while a completely disordered
conformation will have an Saβ value near zero. We used the PLUMED ANTIBETARMSD
collective variable [87,88] to perform the relevant calculations post hoc. Block averaging
was used to compute both the mean and standard deviation over the sampled trajectories.
Dihedral angle and hydrogen bonding analyses were performed using the MDAnalysis
package [89,90]. pKa analysis was performed using the DelPhiPKa webserver [91,92].
Default settings were used for all non-MD predictor methods. Three-dimensional protein
structure figures were generated using PyMOL [76].
3. Results
3.1. Mutations Have Differential Effects on Kelch’s β-Sheets
Saβ (Equation (1)) was calculated over the final 5µs of each trajectory in order to
characterize the effects of the mutations on the Kelch β-propeller, a collection of anti-
parallel β-blades. We found that the experimentally characterized destabilizing mutations
(G333C, G379D, G430C, R413L and G476R) tended to decrease Saβ relative to the wild type,
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while the neutral/stabilizing mutations (G350S, G364C, R415G, A427V and R470C/H/S)
tended to increase it or had little effect. All the destabilizing mutations resulted in a two or
more point decrease in Saβ (∆Saβ < −2), while the G430C and G476R mutations resulted in
decreases of more than four points (Figure 2).
Figure 2. Mutagenic effect on Saβ of Kelch. The average change in Saβ (Equation (1)), relative to the
wild type was calculated and plotted along with the standard deviation. The colors of the bars denote
the documented effect of the given mutation [70–72]: red (destabilizing), blue (neutral/stabilizing)
and orange (unknown or neutral/stabilizing). Sampling was performed over the final 5µs.
With respect to the neutral/stabilizing mutations, A427V and G350S resulted in
moderate decreases in Saβ (∆Saβ ≥ −2), while G364C and R415G resulted in no change and
an increase, respectively. Notably, the ANCHOR mutation R470C and its variant R470H
resulted in increases in Saβ.
We also considered the individual blades with respect to Saβ. In these cases, a per-
residue Saβ (denoted herein as 〈Saβ〉) was used to account for the small differences in the
individual blade lengths within the Kelch propeller. Unsurprisingly, the blade-wise effects
of the mutations tended to correlate with their location (Figure 3). Those blades where the
destabilizing mutations were directly or closely situated, G333C (blade I), G379D (blade
II), R413L (blade II-III linker loop) and G430C (blade III), showed the largest respective
decreases. Interestingly, G476R located in β-blade IV, resulted in decreases in all but one of
the six blades. Collectively blades I, II and III showed relatively larger increases compared
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to blades IV, V and VI irrespective of mutation. This was also true of the wild-type structure,
which showed a blade-dependent Saβ, where the first three blades of Kelch had moderately
lower 〈Saβ〉 values than the final three (Figure 4).
Figure 3. Mutagenic effect on the blade-wise Saβ of Kelch. The average change in Saβ (Equation (1)) (per residue), relative
to the wild type was calculated and plotted along with the standard deviation for each β-blade. The colors denote the
documented effect of the given mutation [70–72]: red (destabilizing), blue (neutral/stabilizing) and orange (unknown or
neutral/stabilizing). Hatched bars indicate that the mutation is within that particular blade. Sampling was performed over
the final 5µs.
3.2. Stabilizing and Destabilizing Mutations Both Result in Global Structural Deformation
The root mean square deviation (RMSD) was calculated over the final 5µs of each
trajectory. The RMSD is a measure of the average deviation of all the backbone atoms from
their initial positions. A higher relative value indicates increased structural deviation and
deformation, while a lower relative value indicates reduced deviation. For all but three
mutations, larger deviations than the wild type were observed, with mutations G476R and
G379D showing the greatest deviations (Figure 5). R470C and R470H were the only mutations
that showed less conformational fluctuation than the wild type. We also considered the
individual blades with respect to the RMSD. In these cases, a per-residue RMSD (denoted
herein as 〈RMSD〉) was used to account for the small differences in the individual blade
lengths within the Kelch propeller. Unlike 〈Saβ〉, the destabilizing and neutral/stabilizing
blade-wise effects of the mutations were less correlated with their location and documented
effect (destabilizing: G333C, G379D, G430C, R413L and G476R; stabilizing/netural: G350S,
G364C, R415G, A427V and R470C/H/S) [70–72] (Figure 6).
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Figure 4. Average blade-wise Saβ and RMSD in the Kelch domain. The average Saβ (Equation (1)) (per residue) and RMSD
(per residue) was calculated and plotted along with the standard deviation for each β-blade in the wild-type Kelch. The
average over all the mutants (both stabilizing and destabilizing) was also calculated and plotted. Sampling was performed
over the final 5µs.
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Figure 5. Mutagenic effect on RMSD of Kelch. The average change, relative to the wild type, of the RMSD was calculated
and plotted along with the standard deviation. The colors denote the documented effect of the given mutation [70–72]: red
(destabilizing), blue (neutral/stabilizing) and orange (unknown or neutral/stabilizing). Sampling was performed over the
final 5µs.
While overall the destabilizing mutations tended to increase deviations, particularly
in those blades where they are directly or closely situated, some notable behavior was
observed. In β-blades III and IV, three neutral/stabilizing mutations G350S, G364C and
A427V resulted in increases in the RMSD. We also note that the G476R mutation in β-blade
IV resulted in notable deviations in all six blades. Similar to 〈Saβ〉, irrespective of mutation,
blades II and III of Kelch had higher 〈RMSD〉 values than the others (Figure 4). The
RMSD, mRMSD and radius of gyration were also computed in a time-dependent fashion
(Figures S1–S4).
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Figure 6. Mutagenic effect on the blade-wise RMSD of Kelch. The average change of the RMSD (per residue), relative
to the wild type was calculated and plotted along with the standard deviation for each β-blade. The colors denote the
documented effect of the given mutation [70–72]: red (destabilizing), blue (neutral/stabilizing) and orange (unknown or
neutral/stabilizing). Hatched bars indicate the mutation is within that particular blade. Sampling was performed over the
final 5µs.
3.3. Destabilizing Mutations Shift the Backbone Dihedrals of Kelch
The backbone torsion angles were calculated over the final 5µs of each trajectory
in order to elucidate the effects, or lack thereof, of the various mutations on the wild
type dihedral structure. The analysis indicated that while none of the neutral/stabilizing
mutations had a significant effect on the dihedral sampling space, all of the destabilizing
mutations resulted in significant shifts (Figure 7); the sampling spaces of G333C, G379D
and G430C all shifted from a glycine allowable region (right hand side of the plot) to
a β-sheet region under mutation. Unlike the other structural glycines, the sampling of
the G476R mutation remained in the glycine allowable region; however, a much larger
space was sampled therein. The R413L mutation resulted in the smallest shift among the
destabilizing mutations, continuing to sample within the β-sheet region.
3.4. Loss of Hydrogen Bonds Due to Destabilizing Mutations
All potential hydrogen bonds (main-chain/main-chain, main-chain/side-chain and
side-chain/side-chain) involving the mutated residues and their corresponding propor-
tional lifetimes relative to the wild type were calculated over the final 5µs of each trajectory
in order to elucidate their effects on the the hydrogen bond network of the Kelch domain.
Exact lifetimes and hydrogen bonding partners are provided in Table S1.
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The destabilizing mutants R413L and G333C both resulted in significant drops in the
hydrogen bond lifetime relative to the wild type (Figure 8). Conversely, the stabilizing
mutants R415G and A427V both resulted in increases in the lifetimes. The ANCHOR
mutation R470C resulted in a decrease in the hydrogen bond lifetime with D422.
Not all the mutations directly affected the hydrogen bonding network of Kelch.
The notable increases in the RMSD, and decreases in Saβ, as well as the unique back-
bone dihedral pattern of G476R (Figure 7), led us to take a closer look at this buried amino
acid. We identified a nearby arginine (Figure 9), R507, that forms hydrogen bonds with
G477, L484, G523 and S533, all of which were significantly disrupted or completely lost
as a result of the G476R mutation. Exact lifetimes and hydrogen bonding partners are
provided in Table S2. Analysis of the residue-wise contact map revealed similar trends to
those observed in the hydrogen bonding (Figure S5).
Figure 7. Mutagenic effect on the backbone dihedrals of the Kelch domain. The Ramachandran plots of the dihedrals for all
mutations. The left plot depicts the wild-type dihedral space and the right plot the mutant dihedral space. The colors of
the plot titles denotes the documented effect of the given mutation [70–72]: red (destabilizing), blue (neutral/stabilizing)
and orange (unknown or neutral/stabilizing). A bivariate kernel density estimate [93,94] was used for plotting with a blue
through red frequency map. Sampling was performed over the final 5µs of trajectory.
3.5. Limited Fluctuations at Both the ANCHOR-Mutant Mutation Site and NRF2 Binding Site
The root mean square fluctuation (RMSF) was calculated over the final 5µs of the
R470C, R470H, R470S and wild-type trajectories. The RMSF is a measure of the average
geometric deviation of a residue from its initial position. An RMSF near zero indicates that
a residue spends most of the time constrained to its initial position. Unstructured loop
and coil regions tend to have higher RMSF values, while structured helical and β-sheet
regions tend to have lower values. The RMSF at and around the R470C, R470H and R470S
mutation sites resulted in minimal changes from the wild type; however, the fluctuations
at R470C and R470H were the lowest of the mutations considered (Figure 10). Notably, all
of the R470 mutations resulted in significantly higher fluctuations at residues flanking the
mutation site (i.e., <463 and >477) compared to the wild type. The ANCHOR mutants are
believed to increase binding affinity of KEAP1 for NRF2 via backbone perturbations that
alter the binding site [70]. Residues identified by PISA (Proteins, Interfaces, Structures and
Assemblies) [95] to be involved in hydrogen-bonding with the Neh2 domain of NRF2 (Y334,
G364, R380, N382, N414, R415, R483, S508, Q530, S555 and S602) were examined. While
only minor effects due to the mutations were observed, the R470H and R470C mutations
tended to show the lowest fluctuations at binding site residues (Figure 11). For the Y334,
S508 and S555 residues, reduced fluctuations were observed for all the mutations compared
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to the wild type. Notably, the R470C mutation resulted in the highest fluctuation at R483,
which is the closest binding site residue in the protein sequence.
Figure 8. Mutagenic effect on the hydrogen bonding network of the Kelch domain. Wild type or mutant hydrogen bonds
that existed for ≥20% of the sampled trajectory are considered in the calculation. Heavy atoms involved in bonding are
connected via solid lines to a central orange “atom” while corresponding bonding partners are connected via dotted lines.
Relative hydrogen bond existence times as a percent of the total trajectory (increase relative to wild type: blue, decrease
relative to wild type: red) are indicated along each dotted line (i.e., |32.3% (mutant lifetime)–38.5% (wild type lifetime)
| = | − 6.2| ≈ 6 decrease). The colors of the plot titles denote the documented effect of the given mutation [70–72]: red
(destabilizing), blue (neutral/stabilizing) and orange (unknown or neutral/stabilizing). Sampling was performed over the
final 5µs of trajectory.
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Figure 9. Effect of G476R mutant on the hydrogen bonding of R507. The left panel shows the hydrogen bond network of
R507. Wild-type and G476R mutant hydrogen bonds that existed for ≥10% of the sampled trajectory are considered in
the calculation. Heavy atoms of R507 involved in bonding are connected via solid lines to a central orange “atom”, while
corresponding bonding partners are connected via dotted lines. Relative hydrogen bond existence times as a percentage of
the total trajectory (increase relative to wild type: blue, decrease relative to wild type: red) are indicated along each dotted
line (i.e., |32.3% (mutant lifetime)–38.5% (wild type lifetime) | = | − 6.2| ≈ 6 decrease). Sampling was performed over the
final 5µs of trajectory. The right panel shows the three-dimensional position of key hydrogen bonding partners of R507.
The top structure is the PDB of the Kelch domain (ID: 2FLU [73]), while the bottom structure is taken from the final frame of
one of the G476R trajectories. Orange atoms belong to the G476 or R476 residue, green atoms to R507 and cyan atoms to the
hydrogen bonding partners. Predicted hydrogen bonds are depicted in the top structure with yellow dashes.
Figure 10. Fluctuations at the ANCHOR mutation site. Sampling was performed every 10 ns over the
final 5µs of trajectory. The root mean square fluctuations of the wild type and the ANCHOR mutant
(R470C) and variants (R470H/R470S) were calculated at the mutation site. The mutation lies in the
β-turn region connecting two strands in blade IV of the Kelch domain. Sampling was performed
over the final 5µs of trajectory.
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Figure 11. Effect of the ANCHOR mutations on binding site fluctuations. The root mean square fluctuations of the wild
type and the ANCHOR mutant (R470C) and variants (R470H/R470S) was calculated at the residues involved in binding the
ETGE (PDB: 2FLU [73]) or DLG (PDB: 3WN7 [96]) peptides as determined by PISA [95]. Sampling was performed over the
final 5µs of trajectory.
4. Discussion
4.1. Structural Mutation Prediction
The dynamic structural analysis clearly indicates that different mutants have different
effects on protein structure, and MD simulations can produce ensembles describing behav-
ior that is in close agreement with the reported effects [70–72]; specifically, that the G333C,
G379D, R413L, G430C and G476R mutants are destabilizing, while the G350S, G364C,
R415G, A427V, R470C, R470H and R470S mutants are neutral/stabilizing. Our results
demonstrate that MD can perform very well in predicting the effects of mutations on the
Kelch domain of KEAP1 (Figure 12) and can provide insights that are often inaccessible to
static in silico methods.
For five of the mutations, G333C, G379D, R413L, G430C and G476R, the structural
analysis points to effects that are destabilizing: significant decreases in the anti-parallel
β-strand content, large shifts in the dihedral sampling space and loss of hydrogen bonds
all indicate mutagenic effects that are destabilizing. Not all the destabilizing mutations
appear to have the same effects on the backbone dihedral angles and hydrogen bonding,
however. Mutations of the structural glycines, G333C, G379D and G430C, all resulted in
significant shifts in the backbone dihedrals, while hydrogen bonding was not severely
affected. Conversely, the R413L and G476R mutations resulted in more constrained shifts
in the backbone dihedrals. The local hydrogen bonding network, however, both directly
and indirectly, was significantly disrupted.
For three of the mutations, G350S, G364C and R415G, the structural analysis is simi-
larly clear and points to effects that are neutral/stabilizing. High Saβ, limited shifts in the
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backbone dihedrals, and limited changes in the hydrogen bonding networks all suggest
mutagenic effects that are neutral or even improve stability.
Figure 12. Performance of methods for predicting protein stability. Relative predicted effect (destabilizing: red, stabilizing:
blue) is based on the normalized value for each method (most destabilizing mutation predicted by a given method is
assigned a score of 1, while the most stabilizing is assigned a score of 0). In some cases, the assignment is strictly binary.
Overall predictive score is based on the number of “correct” predictions (number of predicted mutation effects that agree
with previous experimental findings). Abbreviations are used for some of the in silico methods, and these are indicated as
follows: Exp.: In vitro effect [70–72], Sim.: predicted effect from the MD analysis performed herein, PP2: PolyPhen-2 [21],
SIFT [22], SDM [27], DM: DynaMut [46], ECM: EnCoM [32], CSM: mCSM [37], MUT: I-Mutant 3.0 [23,24] and DDG:
DeepDDG [33].
For all but one of the nine mutations, A427V, the observed dynamic behavior is dis-
tinctly either destabilizing (G333C, G379D, G430C, R413L and G476R) or neutral/stabilizing
(G350S, G364C, R415G, A427V and R470C/H/S), and agrees with published findings
(stabilizing: G350S, G364C, R415G and R470C; destabilizing: G333C, G379D, G430C, R413L
and G476R) [70–72]. A427V showed decreases in Saβ; however, we observed no significant
shift in the backbone dihedrals under mutation. Furthermore, favorable increases in the hy-
drogen bonding, and only a limited increase in the RMSD, all suggest this mutant does not
have a significant effect on stability; however, given the Saβ, we classify it as inconclusive.
We note that in using the findings [72] that involved the attempted purification of the
wild type and the nine mutant Kelch proteins, we assume that the insoluble mutants were
destabilizing and those that could be purified were neutral/stabilizing. There is an inherent
limitation in such an assumption as protein solubility is not entirely dependent on protein
stability. The inability to work with some of these protein mutants experimentally, as was
the case in this previous work [72], underscores one of the shortcomings of experimental
methods and highlights how MD can be used to extract additional information from
systems that are difficult, if not impossible to analyze at the bench.
As a protein stability prediction method, our plain-MD approach showed an above-
average accuracy when compared to other in silico methods. Concluding that those
mutations that result in significant decreases in Saβ are destabilizing, and that those that
result in minimal changes or increases are neutral/stabilizing, gives this method an overall
predictive accuracy of 89% assuming the correctness of previous studies [70–72] and that
the R470C and associated variants (R470H and R470S) are neutral/stabilizing [70,71].
This compares well to eight alternative in silico methods (Figure 12, Table 1). Given the
performance of the Saβ for classifying the effect of amino acid substitutions on Kelch
stability, future studies looking at this domain may benefit from utilizing Saβ as a collective
variable in a metadynamics-based approach [97].
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Table 1. Performance of methods for predicting mutagenic effect. PP2, SIFT and PMC use dimension-
less values, while the remaining methods use ∆∆G (kcal/mol). Abbreviations are used for some of
the in silico methods and these are indicated as follows: Exp.: In vitro effect [70–72], Sim.: predicted
effect from the MD analysis performed herein, PP2: PolyPhen-2 [21], SIFT [22], PMC: PoPMuSiC [29],
SDM [27], DM: DynaMut [46], ECM: EnCoM [32], CSM: mCSM [37], MUT: I-Mutant 3.0 [23,24] and
DDG: DeepDDG [33]. Exp. and Sim. categories use the following abbreviations: destabilizing (D),
neutral/stabilizing (S/N) or inconclusive (I).
Mutant Exp. Sim. PP2 SIFT PMC SDM DM ECM mCSM MUT DGG
G333C D D 1.00 0.05 / −1.45 −0.76 1.25 −1.92 −0.63 −1.98
G350S S/N S/N 0.99 0.22 / −3.40 −1.00 0.19 −1.13 −1.15 −0.69
G364C S/N S/N 1.00 0.03 / −1.37 0.81 0.35 −1.48 −0.70 −1.46
G379D D D 1.00 0.00 / −2.72 −1.15 0.98 −2.99 −0.79 −2.83
R413L D D 1.00 0.00 −0.58 0.04 0.24 −0.38 −0.68 −0.71 −1.23
R415G S/N S/N 0.95 0.43 / 2.18 −0.70 −0.80 −1.42 −0.86 −0.40
A427V S/N I 1.00 0.00 −0.59 0.57 3.16 0.40 0.22 −0.73 0.26
G430C D D 1.00 0.00 / −1.52 −0.33 1.14 −1.80 −0.79 −1.77
R470C S/N S/N 0.88 0.01 / −0.51 −0.75 −0.42 −0.13 −1.00 −0.22
R470H S/N S/N 1.00 0.03 / −0.14 −0.84 −0.31 −0.82 −1.26 −0.28
R470S S/N S/N 0.99 0.08 / −1.12 −0.57 −0.27 −0.23 −1.21 −0.42
G476R D D 1.00 0.00 / −3.19 −1.36 0.75 −0.99 −0.62 −2.11
4.2. β-Blades I, II and III Are Less Stable than Blades IV, V and VI
The blade-wise analysis of the wild-type structure clearly indicates lower Saβ values
and higher fluctuations in β-blades I, II and III, and higher Saβ values and lower fluctuations
in β-blades IV, V and VI (Figure 4). Furthermore, mutations G333C, G379D, R413L and
G430C, all located in blades I-III, show highly destabilizing effects that are almost entirely
localized to these same blades (Figure 3). Interestingly, according to the COSMIC database,
the missense mutation count of the six blades of Kelch is 71, 64, 79, 62 (+24 ANCHOR
mutant site), 45 and 53, respectively; that is, the total number of mutations in the first
three blades is 214, and the total in the final three is 160 (+24). Given this, it is tempting
to hypothesize that the cancerous mutations in Kelch preferentially cluster in structurally
significant regions in order to destabilize the domain and weaken NRF2 binding.
4.3. ANCHOR Mutant
The group of mutants referred to as “additionally NRF2-complexed hypomorphs”
(ANCHOR) are thought to confer an increased binding affinity to KEAP1 for NRF2 [70,71].
One of these mutants, R470C, sits distant (Figure 1) from the NRF2 binding site of the
Kelch domain in KEAP1 and is believed to allosterically increase affinity via backbone
perturbations, resulting in a conformational change in the binding pocket [71]. This is
somewhat paradoxical as R470C is the most frequently listed missense mutation in KEAP1
in the COSMIC database [69].
Dynamic analysis of the residues in the Kelch domain predicted to hydrogen bond
with NRF2, reveals that R470C, R470H and R470S have relatively unchanged fluctuations
at these sites compared to the wild type, with R470C and R470H tending to show the
smallest fluctuations overall (Figure 11). With respect to global dynamics, the R470C and
R470H mutations both resulted in increases in Saβ and decreases in RMSD compared to
the wild type. Whether these minor fluctuations induced by R470C result in increased
binding affinity, as previously postulated [71], cannot be concluded. However, in agree-
ment with these previous results, changes to the binding pocket residues were observed.
Although differences in the mutagenic effects are evident, why it is that R470C occurs twice
as frequently as R470H and eight times as frequently as R470S in the COSMIC database is
not entirely explained by these dynamics data.
It is a documented phenomenon that, on a proteome level in cancer, net gain of
cysteine, histidine and tryptophan and a net loss of arginine occur [98]. These mutations
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may confer a unique beneficial phenotype to cancer. One possibility is that the mutation to
cysteine provides another site for post-translational modification (PTM). C470 is highly
solvent accessible with a relative solvent accessibility of 0.58 and has a predicted pKa of
7.73, making it a possible nucleophile and target for electrophilic covalent modification [99].
Several other cysteines, C368 (pKa: 6.93), C434 (pKa: 6.63), C489 (pKa: 6.99) and C583
(pKa: 7.29), are known to be modified in the Kelch domain and have predicted pKa values
similar to that at C470 and all of these are below the pKa of a normal cysteine thiol
(∼9.5) [91,100].
Modification by sulforaphane has been previously shown to result in NRF2 activation.
While C151 is the predominant sulforaphane sensor in KEAP1, C489 and C368, both in
the Kelch domain, have been shown to readily form adducts with sulforaphane [101,102].
Additionally, previous computational modeling revealed that modification of C434 and
C368 by glutathione resulted in structural changes in Kelch that would impair KEAP1/NRF2
binding [103], and modification of C434 by 8-nitro-cGMP has been shown to activate
NRF2 [104]. We do note that Eggler et al. previously found that modification of the cys-
teines of KEAP1 is insufficient to significantly disrupt binding to NRF2, and that disruption
of the KEAP1-CUL3 interaction is the probable mode of action [105]. In any case, a modifi-
cation of R470C may still partially explain its observed frequency in the cancer database.
Given the nature of the KEAP1-NRF2 pathway, increased dissociation would result in
increased nuclear accumulation and the upregulation of key genes that are believed to
confer a chemoprotective phenotype to cancer cells [68].
Additional MD simulations using a PTM-parameterized forcefield [78,106,107] and
a mutant structure with an explicitly modified cysteine is an approach that may provide
additional insight into the possible mutagenic effect of R470C. While our findings do not
rule out the possibility of a direct allosteric effect of the R470C mutant on the binding
site, an absence of significant structural dynamics at the binding site points to a less
trivial explanation.
5. Conclusions
Our work provides additional insight into the structural dynamics of mutants that
could not be analyzed experimentally, painting a more complete picture of their mutagenic
effects [72]. These findings also appear to point to a preferential targeting of protein stability
in cancer mutants, which to our knowledge is being reported for the first time. In addition,
our analysis points to Saβ (Equation (1)) being a superior metric compared to RMSD for
characterizing the effects of the mutations on the Kelch propeller. While this cannot be
employed for all systems, when applicable, the use of Saβ or the associated parallel β-strand
(Spβ) and α-helical (Sα) order parameters [86] would provide insights beyond the standard
RMSD, RMSF and radius of gyration metrics. Furthermore, our results reveal that the
R470C ANCHOR mutant induces only minor structural changes in the binding site of Kelch
relative to the wild type, suggesting that a direct allosteric effect of the mutant may not
fully explain its potential mode of action and frequent occurrence in the cancer database.
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